Indrayani Biotech Ltd

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 August 2026, providing investors with the latest insights into its performance and outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 04 August 2026, providing investors with the latest comprehensive analysis.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, but the analysis and financial metrics presented here reflect the stock’s current position as of 09 July 2026.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 June 2026, providing investors with an up-to-date view of its performance and outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 20 March 2026, providing investors with the latest insights into its performance and outlook.

Indrayani Biotech Ltd, a micro-cap player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.6.1 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indrayani Biotech Ltd has touched a new 52-week low of Rs.7.25 today, marking a significant decline in its share price amid a sustained downward trend. The stock has now recorded losses for three consecutive days, accumulating a negative return of 11.26% over this period, reflecting ongoing pressures within the Other Agricultural Products sector.

Indrayani Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.7.25 today, marking a significant milestone in its ongoing downward trajectory. The stock has been under pressure for several sessions, reflecting persistent challenges within the company and the broader sector.

Indrayani Biotech Ltd’s shares declined to a fresh 52-week low of Rs.7.54 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has now underperformed considerably against its sector and benchmark indices over the past year.